Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             129 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 24 A cost-effectiveness analysis on the use of erlotinib (Tarceva) in the maintenance treatment of locally advanced or metastatic NSCLC patients with stable disease (SD) as best response to induction McNamara, S.
 2011
 71 S1 p. S8-
1 p.
 artikel
2 41 Adequacy of EBUS transbronchial needle aspirates to facilitate the histological sub-classification of thoracic malignancy Brown, L.
 2011
 71 S1 p. S14-
1 p.
 artikel
3 59 A joint non medical prescribing clinic for the management of patients requiring tyrosine kinase inhibitors and chemotherapy treatments led by a lung cancer clinical nurse specialist and a Macmillan pharmacist Bowden, E.M.
 2011
 71 S1 p. S20-
1 p.
 artikel
4 19 A Kent and Medway Cancer Network (KMCN) audit of first-line treatment with cisplatin/pemetrexed (CisPem) in non squamous non-small cell lung cancer (NSCLC) Letsa, I.
 2011
 71 S1 p. S7-
1 p.
 artikel
5 73 A lung cancer study day can improve awareness of prognosis amongst allied healthcare professionals Phelps, J.
 2011
 71 S1 p. S25-
1 p.
 artikel
6 77 A multidisciplinary complex perioperative intervention to reduce complications and enhance recovery after lung resection surgery Abdelaziz, M.
 2011
 71 S1 p. S26-
1 p.
 artikel
7 76 A multi-professional health and well being clinic incorporating holistic needs assessment Guerin, M.
 2011
 71 S1 p. S26-
1 p.
 artikel
8 15 An audit of follow-up practice following completion of first-line chemotherapy for patients with advanced NSCLC at St James's Institute Of Oncology, Leeds Salter, A.
 2011
 71 S1 p. S5-S6
2 p.
 artikel
9 17 An audit of the uptake of adjuvant chemotherapy following surgery with curative intent in NSCLC patients at St James's Institute of Oncology, Leeds George, D.R.
 2011
 71 S1 p. S6-
1 p.
 artikel
10 96 An audit of the use of radiotherapy for brain metastases from lung cancer Gahir, D.
 2011
 71 S1 p. S33-
1 p.
 artikel
11 78 An evaluation of the benefits of the nurse practitioner role to thoracotomy patients and staff in the West of Scotland Heart and Lung Centre Devenay, S.
 2011
 71 S1 p. S26-S27
2 p.
 artikel
12 106 An examination of the recruitment of non-small cell lung cancer (NSCLC) patients with brain metastases (BM) to the QUARTZ Clinical Trial at the Christie Helbrow, J.
 2011
 71 S1 p. S37-
1 p.
 artikel
13 98 A paradigm shift IMRT enables radical treatment in locally advanced lung cancer patients who would have been treated with palliative intent with 3D conformal radiotherapy (3D CRT) Shrimali, R.K.
 2011
 71 S1 p. S34-
1 p.
 artikel
14 65 Are we achieving lung cancer waiting time guidelines? Connolly, E.
 2011
 71 S1 p. S22-
1 p.
 artikel
15 79 Audit of correct administration of DVT prophylaxis for patients undergoing thoracic surgery for the resection of pulmonary carcinomas Lodge, C.
 2011
 71 S1 p. S27-
1 p.
 artikel
16 115 Audit of high dose palliative radiotherapy survival outcomes in patients with non-small cell lung cancer (NSCLC) in Leeds between 1999 and 2009 Murray, P.F.
 2011
 71 S1 p. S40-
1 p.
 artikel
17 95 Audit of the management of spinal cord compression (pre-NICE guideline implementation) Gahir, D.
 2011
 71 S1 p. S33-
1 p.
 artikel
18 94 Audit on outcome of patients with brain metastases treated with palliative whole brain radiotherapy (WBRT) over a period of 12 months, a single institution's experience Chaw, C.L.
 2011
 71 S1 p. S32-S33
2 p.
 artikel
19 Author index 2011
 71 S1 p. S45-S48
4 p.
 artikel
20 44 Bimodality surveillance of patients at high risk for lung cancer Brown, L.
 2011
 71 S1 p. S15-
1 p.
 artikel
21 85 Breathlessness in advanced intrathoracic malignancy - a framework for intervention Peel, T.
 2011
 71 S1 p. S29-
1 p.
 artikel
22 32 Can EBUS/EUS FNA specimens be used to accurately assess cell type in non-small cell lung carcinomas? Wallace, W.
 2011
 71 S1 p. S11-
1 p.
 artikel
23 99 Comparison of 4DCT derived PTV vs. free-breathing derived PTV in patients receiving radical radiotherapy for NSCLC - volumetric and dosimetric analysis Franklin, A.
 2011
 71 S1 p. S34-S35
2 p.
 artikel
24 113 Cone beam computed tomography (CBCT) based adaptive radiotherapy for lung cancer? The Christie experience Shrimali, R.K.
 2011
 71 S1 p. S39-
1 p.
 artikel
25 93 Cone-beam CT (CBCT) assessment of intra-fraction motion during stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC) Qureshi, A.
 2011
 71 S1 p. S33-
1 p.
 artikel
26 100 Continuous hyperfractionated accelerated radiotherapy (CHART) for patients with inoperable non-small cell lung Cancer (NSCLC): 10 year experience of the Exeter Oncology Centre Alip, A.
 2011
 71 S1 p. S35-
1 p.
 artikel
27 117 CONVERT: Concurrent Once-Daily Versus Twice-Daily Radiotherapy - a phase III randomised controlled trial for patients with LS SCLC and good performance status Faivre-Finn, C.
 2011
 71 S1 p. S40-S41
2 p.
 artikel
28 28 CT guided lung biopsy - providing patient information in a multidisciplinary setting Borthwick, D.
 2011
 71 S1 p. S10-
1 p.
 artikel
29 62 Does GP clinical history influence radiologists' interpretation of chest radiographs or reliably predict eventual diagnosis of lung malignancy? Chatterji, S.
 2011
 71 S1 p. S21-
1 p.
 artikel
30 22 Does histological subtype determine response to chemotherapy in advanced non-small cell lung cancer? A retrospective study Walkington, L.A.
 2011
 71 S1 p. S8-
1 p.
 artikel
31 33 Does modality of biopsy impact on ability to determine EGRF status in non-small cell lung cancer? Pond, Z.
 2011
 71 S1 p. S11-S12
2 p.
 artikel
32 70 Dying from lung cancer - a study of end of life care Shipley, M.D.
 2011
 71 S1 p. S24-
1 p.
 artikel
33 83 Early results of a newly developed patient reported experience measure for the National Improving Lung Cancer Outcomes Project Draffan, J.
 2011
 71 S1 p. S28-S29
2 p.
 artikel
34 57 Effectiveness of decision making at lung cancer multidisciplinary team meetings Storrar, W.
 2011
 71 S1 p. S20-
1 p.
 artikel
35 25 EGFR mutation analysis in Welsh population Rimi, F.T.
 2011
 71 S1 p. S9-
1 p.
 artikel
36 9 EGFR mutation in non-small cell lung cancer: one year of laboratory testing du Parcq, P.A.
 2011
 71 S1 p. S3-
1 p.
 artikel
37 42 Endobronchial ultrasound (EBUS)-guided transbronchial biopsy/brush of peripheral pulmonary nodules: an initial cancer centre experience Brown, L.
 2011
 71 S1 p. S15-
1 p.
 artikel
38 45 Epidermal growth factor receptor (EGFR) mutation testing - the Manchester experience Mitchell, C.
 2011
 71 S1 p. S15-S16
2 p.
 artikel
39 80 Evaluating the care and experiences of patients with spinal cord compression Warnock, C.
 2011
 71 S1 p. S27-
1 p.
 artikel
40 68 Evaluating the use of holistic needs assessment tools with patients with lung cancer Halkyard, E.
 2011
 71 S1 p. S23-S24
2 p.
 artikel
41 69 Evaluation of an educational intervention - an everyday toolbox for the management of breathlessness in advanced disease Hillcox-Smith, A.
 2011
 71 S1 p. S24-
1 p.
 artikel
42 23 Experience of erlotinib for non-small cell lung cancer (NSCLC) at the Exeter Oncology Centre Minear, F.G.
 2011
 71 S1 p. S8-
1 p.
 artikel
43 37 Experiences in epidermal growth factor receptor tyrosine kinase mutation testing in South East Wales Currie, S.
 2011
 71 S1 p. S13-
1 p.
 artikel
44 7 Expression and regulation of IL-23 in NSCLC Gray, S.G.
 2011
 71 S1 p. S3-
1 p.
 artikel
45 55 Expression of5&12 lipoxygenase in malignant pleural mesothelioma Agarwal, V.
 2011
 71 S1 p. S19-
1 p.
 artikel
46 56 Expression of PTEN in malignant pleural mesothelioma Agarwal, V.
 2011
 71 S1 p. S19-S20
2 p.
 artikel
47 2 Expression of the CXC (ELR+) receptor, CXCR2, is reactivated by epigenetic means in non-small cell lung cancer Baird, A.M.
 2011
 71 S1 p. S1-
1 p.
 artikel
48 52 Expression of the receptor MST1R/RON and its ligand MSP in malignant pleural mesothelioma Gray, S.G.
 2011
 71 S1 p. S18-
1 p.
 artikel
49 31 Histolopathological trends in HIV-associated lung cancer Merchant, S.
 2011
 71 S1 p. S11-
1 p.
 artikel
50 103 Impact of integration of fused FDG-PET and CT information for GTV delineation Webster, G.J.
 2011
 71 S1 p. S36-
1 p.
 artikel
51 97 Implementation of stereotactic body radiotherapy (SBRT) for non-small cell lung cancers in the UK: update from the SBRT Consortium Jain, P.
 2011
 71 S1 p. S34-
1 p.
 artikel
52 40 Improved resection rates following a campaign to raise awareness of cough as an early lung cancer symptom Athey, V.
 2011
 71 S1 p. S14-
1 p.
 artikel
53 26 Improving patient comfort during medical thoracoscopy Powell, H.A.
 2011
 71 S1 p. S9-
1 p.
 artikel
54 48 Indwelling pleural catheters reduce inpatient stay for patients with malignant pleural effusion Munson, C.F.
 2011
 71 S1 p. S16-S17
2 p.
 artikel
55 29 In the absence of EBUS, blind TBNA is an important tool for patients with suspected thoracic malignancy Shepherd, K.
 2011
 71 S1 p. S10-
1 p.
 artikel
56 82 Investigating physical activity levels of lung cancer patients pre-intervention and feasibility of exercise class attendance post-intervention Schofield, E.M.
 2011
 71 S1 p. S28-
1 p.
 artikel
57 87 Is there a need for prospective international database for thymomas? Nagarajan, K.
 2011
 71 S1 p. S30-
1 p.
 artikel
58 92 Junior doctors' confidence around prescribing opiates in thoracic oncology: a survey from a teaching hospital in Bristol, South West England Leahy, A.
 2011
 71 S1 p. S32-
1 p.
 artikel
59 74 Lung cancer patients/carers support - what do they really want? Smith, K.J.
 2011
 71 S1 p. S25-
1 p.
 artikel
60 114 Lung stereotactic body radiotherapy (SBRT) for medically inoperable peripheral stage 1 non-small cell lung cancer (NSCLC): updated results from St James's Institute of Oncology, Leeds Sangha, V.
 2011
 71 S1 p. S39-S40
2 p.
 artikel
61 50 Malignant mesothelioma in the North West - are diagnostic delays affecting survival? Thomson, D.
 2011
 71 S1 p. S17-S18
2 p.
 artikel
62 86 Management of malignant pleural effusions with tunnelled pleural catheters: a single institution experience Noble, J.
 2011
 71 S1 p. S29-S30
2 p.
 artikel
63 3 Maximising archival resources to unravel the transcriptome of squamous cell carcinoma Brown, L.
 2011
 71 S1 p. S1-S2
2 p.
 artikel
64 30 Neck ultrasound and cervical lymph node sampling reduces time to diagnosis for lung cancer Wilsmore, N.
 2011
 71 S1 p. S10-
1 p.
 artikel
65 18 NSCLC second line therapy with erlotinib: review of patients' outcomes Urquhart, G.
 2011
 71 S1 p. S6-
1 p.
 artikel
66 116 Oral topotecan in platinum-refractory small-cell lung cancer: A cancer network experience Stephens, P.
 2011
 71 S1 p. S40-
1 p.
 artikel
67 104 Palliative chemotherapy followed by consolidation radiotherapy in patients with advanced and metastatic non-small cell lung cancer not suitable for radical treatment Eldeeb, H.
 2011
 71 S1 p. S36-
1 p.
 artikel
68 64 Patient choice in lung cancer at the East and North Hertfordshire NHS Trust Succony, L.
 2011
 71 S1 p. S22-
1 p.
 artikel
69 109 Patients with non-small cell lung cancer and brain metastases who received whole brain radiotherapy were they considered for the Quartz trial? Wilson, P.
 2011
 71 S1 p. S38-
1 p.
 artikel
70 47 Pemetrexed for malignant pleural mesothelioma (MPM): updated experience in Northern Ireland Fenton, A.
 2011
 71 S1 p. S16-
1 p.
 artikel
71 16 Pemetrexed for non-squamous non-small-cell lung cancer: experience in Northern Ireland Mulligan, C.
 2011
 71 S1 p. S6-
1 p.
 artikel
72 119 Phase I dose finding study of irinotecan in combination with carboplatin in treatment naive extensive stage small cell lung cancer Nolan, L.
 2011
 71 S1 p. S41-
1 p.
 artikel
73 51 Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and adjuvant chemotherapy in patients with malignant pleural mesothelioma. A 6-year experience Lang-Lazdunski, L.
 2011
 71 S1 p. S18-
1 p.
 artikel
74 124 Predictive prognostic factors of surgically treated intra-pulmonary metastases from colorectal carcinomas: a 30 years retrospective analysis Granato, F.
 2011
 71 S1 p. S43-
1 p.
 artikel
75 34 Prevalence of activating epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer at Glenfield Hospital Leicester Ahmed, S.
 2011
 71 S1 p. S12-
1 p.
 artikel
76 46 Prevalence of EGFR and K-RAS mutation status in clinical practice - relationship to patient characteristics Simpson, T.
 2011
 71 S1 p. S16-
1 p.
 artikel
77 128 Primary lung cancer surgery should be done by VATS (video assisted thoracoscopic surgery) Mehta, V.
 2011
 71 S1 p. S44-
1 p.
 artikel
78 53 Principal results of the feasibility phase of the Mesothelioma and Radical Surgery trial (MARS-feasibility) Treasure, T.
 2011
 71 S1 p. S18-S19
2 p.
 artikel
79 72 Promoting smoking cessation for patients receiving treatment for lung cancer Dowd, I.
 2011
 71 S1 p. S24-S25
2 p.
 artikel
80 49 Proteomic analysis of the mechanism of action of a COX2 Inhibitor (DuP-697) in mesothelioma Agarwal, V.
 2011
 71 S1 p. S17-
1 p.
 artikel
81 127 PulMiCC (Pulmonary Metastasectomy in Colorectal Cancer) trial Treasure, T.
 2011
 71 S1 p. S44-
1 p.
 artikel
82 110 Quality of life after treatment for brain metastases: interim data from the MRC QUARTZ clinical trial. Part one, baseline characteristics, survival and QALYs Mulvenna, P.
 2011
 71 S1 p. S38-
1 p.
 artikel
83 111 Quality of life after treatment for brain metastases: interim data from the MRC QUARTZ clinical trial. Part two, symptoms, quality of life and data completion Mulvenna, P.
 2011
 71 S1 p. S39-
1 p.
 artikel
84 101 Radical radiotherapy outcomes for non-small cell lung cancer (NSCLC) - Bart's experience 2000–2008 Eminowicz, G.
 2011
 71 S1 p. S35-
1 p.
 artikel
85 102 Radical radiotherapy outcomes in stage I and II non-small cell lung cancer patients unfit for surgery Ekatah, G.
 2011
 71 S1 p. S35-S36
2 p.
 artikel
86 108 Radical vs high-dose palliative radiotherapy in NSCLC patients over 75 at Plymouth Hospitals NHS Trust Meissner, M.
 2011
 71 S1 p. S38-
1 p.
 artikel
87 84 Raising the profile of lung cancer: the role of the UK Lung Cancer Coalition Peake, M.D.
 2011
 71 S1 p. S29-
1 p.
 artikel
88 66 Red flag lung cancer clinic expediates patient pathway in lung cancer Ringrow, S.M.
 2011
 71 S1 p. S22-S23
2 p.
 artikel
89 61 Reducing emergency admissions to hospital through the introduction of an acute lung cancer clinic Hodgson, L.
 2011
 71 S1 p. S21-
1 p.
 artikel
90 89 Repeat local validation of the National Lung Cancer Database (LUCADA) in 2006 and 2009 - how do they compare? Calvert, L.
 2011
 71 S1 p. S30-S31
2 p.
 artikel
91 14 Results of patient satisfaction survey conducted across SE Wales on patients undergoing chemotherapy for lung cancer Brewster, A.
 2011
 71 S1 p. S5-
1 p.
 artikel
92 67 Retrospective audit of a district general hospital (DGH) lung multi-disciplinary team (MDT) - lessons from misses and near-misses of treatment deadline O'Connor, S.J.
 2011
 71 S1 p. S23-
1 p.
 artikel
93 120 Role of PET scanning in upstaging of small cell lung cancer (SCLC) Teo, M.Y.
 2011
 71 S1 p. S41-S42
2 p.
 artikel
94 58 SCAN Lung Group - a patient satisfaction survey Borthwick, D.
 2011
 71 S1 p. S20-
1 p.
 artikel
95 11 Second-line erlotinib in unselected NSCLC: audit of benefit Urquhart, G.
 2011
 71 S1 p. S4-
1 p.
 artikel
96 112 Set-up corrections for lung stereotactic body radiotherapy (SBRT) patients determined by online cone beam CT image guidance Peedell, C.
 2011
 71 S1 p. S39-
1 p.
 artikel
97 123 Small cell lung cancer overall survival, incidence of brain metastases and use of prophylactic cranial irradiation for patients treated in Cambridge during 2005–2009 Harden, S.V.
 2011
 71 S1 p. S42-
1 p.
 artikel
98 122 Small cell lung carcinoma: experience in patients treated with initial chemotherapy or sequential chemotherapy plus radiotherapy 2005–2010 Taylor, P.
 2011
 71 S1 p. S42-
1 p.
 artikel
99 39 Stage migration: lymph node dissection in the era of modern imaging and invasive staging for lung cancer Kirmani, B.H.
 2011
 71 S1 p. S13-S14
2 p.
 artikel
100 121 STOMP: Small cell lung cancer trial of olaparib (AZD2281) as maintenance programme - a randomised, double blind, multicentre NCRN phase II trial Woll, P.J.
 2011
 71 S1 p. S42-
1 p.
 artikel
101 91 Success of bedside talc slurry pleurodesis for malignant pleural effusions: a retrospective analysis Punwani, R.
 2011
 71 S1 p. S31-S32
2 p.
 artikel
102 126 Surgery of tumours invading the thoracic inlet (pancoast tumours): a contemporary experience Lang-Lazdunski, L.
 2011
 71 S1 p. S43-
1 p.
 artikel
103 105 Survival outcomes following high dose palliative thoracic radiotherapy Said, J.
 2011
 71 S1 p. S37-
1 p.
 artikel
104 118 Syndrome of inappropriate antidiuretic hormone (SIADH) in patients with small cell lung cancer & incidence and response to treatment Jellett, L.
 2011
 71 S1 p. S41-
1 p.
 artikel
105 10 Targeting the IGF-1R signalling pathway in non-small cell lung cancer (NSCLC) Forde, L.
 2011
 71 S1 p. S4-
1 p.
 artikel
106 71 Telephone support by lung cancer nurses: results of a national study Dutton, H.
 2011
 71 S1 p. S24-
1 p.
 artikel
107 38 Testing for epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based analysis in North Trent Das, T.
 2011
 71 S1 p. S13-
1 p.
 artikel
108 6 The expression and role of thromboxane synthase in NSCLC: correlation with angiogenic factors and patient survival Cathcart, M.C.
 2011
 71 S1 p. S2-S3
2 p.
 artikel
109 35 The first 12 months of UK diagnostic services for EGFR gene mutations in NSCLC patients Butler, R.
 2011
 71 S1 p. S12-
1 p.
 artikel
110 5 The generation and characterisation of cisplatin resistant non-small cell lung cancer cell lines that display stem-like features Barr, M.
 2011
 71 S1 p. S2-
1 p.
 artikel
111 75 The Mesothelioma Nurse Action Team: developing a national mesothelioma patient information pathway Darlison, L.
 2011
 71 S1 p. S25-S26
2 p.
 artikel
112 90 The National Lung Cancer Audit - year 5 completeness and outcomes and case-mix adjustment Beckett, P.
 2011
 71 S1 p. S31-
1 p.
 artikel
113 13 The predictive value of serum tumour markers in Tyrosine Kinase Inhibitor (TKI) treatment for advanced non-small cell lung cancer (NSCLC) Pearmain, L.
 2011
 71 S1 p. S5-
1 p.
 artikel
114 81 The presentation and management of thymic epithelial malignancies & the Guy's and St Thomas' hospital experience Krieger, L.E.M.
 2011
 71 S1 p. S27-S28
2 p.
 artikel
115 21 The survival benefit of erlotinib in the management of advanced non-small cell lung cancer (NSCLC) in the routine clinical practice; a retrospective study Daverede, L.
 2011
 71 S1 p. S7-
1 p.
 artikel
116 60 The use of distress scores in a dedicated lung cancer clinic Hodgson, L.
 2011
 71 S1 p. S21-
1 p.
 artikel
117 20 The use of erlotinib in NSCLC at the Christie Hospital Hussain, J.
 2011
 71 S1 p. S7-
1 p.
 artikel
118 107 Treatment with continuous, hyperfractionated, accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC): experience from two UK centres Lester, J.E.
 2011
 71 S1 p. S37-S38
2 p.
 artikel
119 36 Twelve months' experience of EGFR mutation testing in the UK Butler, R.
 2011
 71 S1 p. S12-S13
2 p.
 artikel
120 54 University Hospitals of Leicester mesothelioma audit 2006–2009 Brown, V.
 2011
 71 S1 p. S19-
1 p.
 artikel
121 63 Use of a feedback questionnaire to improve effectiveness of MDT Hoda, U.
 2011
 71 S1 p. S22-
1 p.
 artikel
122 12 Use of erlotinib in management of recurrent advanced non-small cell lung cancer. The West Of Scotland experience Hameed, H.
 2011
 71 S1 p. S4-S5
2 p.
 artikel
123 88 Using multimedia information to improve outcomes for lung cancer patients and carers Dickson, J.
 2011
 71 S1 p. S30-
1 p.
 artikel
124 43 Variations in practice of intraoperative staging for lung cancer resection Sharkey, A.
 2011
 71 S1 p. S15-
1 p.
 artikel
125 4 VEGF is an autocrine survival factor in non-small cell lung cancer Barr, M.
 2011
 71 S1 p. S2-
1 p.
 artikel
126 125 Vertical ribs osteosynthesis system (VEPTR) combined with ePTFE: a modern reconstruction of a large posterolateral chest wall defect after en-bloc resection for vertebral-T4 NSCLC Berthet, J.P.
 2011
 71 S1 p. S43-
1 p.
 artikel
127 1 Vitamin D axis in lung cancer Millen, A.
 2011
 71 S1 p. S1-
1 p.
 artikel
128 8 Vitamin D levels in patients with lung cancer: a potential cause of confusion? Said, J.
 2011
 71 S1 p. S3-
1 p.
 artikel
129 27 10 years experience of malignant pericardial effusions from a tertiary referral centre Coyle, C.
 2011
 71 S1 p. S9-S10
2 p.
 artikel
                             129 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland